Toggle Health Problems and D

Pneumonia in Egyptian Children 3.6 X more likely if poor Vitamin D Receptor – Aug 2018

Association of vitamin D receptor gene FokI polymorphism and susceptibility to CAP in Egyptian children: a multicenter study

Pediatric Research (2018) https://doi.org/10.1038/s41390-018-0149-y
Heba Abouzeid, NourEldin M. Abdelaal, Mohammed A. Abdou, Amira A. A. Mosabah, Mervat T. Zakaria, Mohammed M. Soliman, Ashraf M. Sherif, Mohammed E. Hamed, Attia A. Soliman, Maha A. Noah, Atef M. Khalil, Mohamed S. Hegab, Alsayed Abdel-Aziz, Shaimaa S. A. Elashkar, Rehab M. Nabil, Adel M. Abdou, Ghada M. Al-Akad & Hany A. A. Elbasyouni


Vitamin D Receptor category has the following

519 studies in Vitamin D Receptor category

Vitamin D tests cannot detect Vitamin D Receptor (VDR) problems
A poor VDR restricts Vitamin D from getting in the cells

See also: 48 studies in the Resveratrol category

It appears that 30% of the population have a poor VDR (40% of the Obese )
Several diseases protect themselves by deactivating the Vitamin D receptor. Example: Breast Cancer
- - - - - - - -
The Vitamin D Receptor is associated with many health problems

Health problems include: Autoimmune (19 studies), Breast Cancer (22 studies), Colon Cancer (13 studies), Cardiovascular (23 studies), Cognition (16 studies), Diabetes (24 studies), Hypertension (9 studies), Infant (22 studies), Lupus (6 studies), Metabolic Syndrome (4 studies), Mortality (4 studies), Multiple Sclerosis (12 studies), Obesity (17 studies), Pregnancy (24 studies), Rheumatoid Arthritis (10 studies), TB (8 studies), VIRUS (36 studies),   Click here for details
Some health problems, such as Breast Cancer, Diabetes, and COVID protect themselves by reducing VDR activation

55 health problems associated with poor VDR

A poor VDR is associated with the risk of 55 health problems  click here for details
The risk of 48 diseases at least double with poor VDR as of Jan 2023  click here for details
Some health problem, such as Breast Cancer reduce the VDR

VDR at-home test $29 - results not easily understood in 2016
There are hints that you may have inherited a poor VDR

How to increase VDR activation

Compensate for poor VDR by increasing one or more:

1) Vitamin D supplement  Sun
Ultraviolet -B
Vitamin D in the blood
and thus in the cells
2) MagnesiumVitamin D in the blood
 AND in the cells
3) Omega-3 Vitamin D in the cells
4) Resveratrol Vitamin D Receptor
5) Intense exercise Vitamin D Receptor
6) Get prescription for VDR activator
   paricalcitol, maxacalcitol?
Vitamin D Receptor
7) Quercetin (flavonoid) Vitamin D Receptor
8) Zinc is in the VDRVitamin D Receptor
9) BoronVitamin D Receptor ?,
10) Essential oils e.g. ginger, curcuminVitamin D Receptor
11) ProgesteroneVitamin D Receptor
12) Infrequent high concentration Vitamin D
Increases the concentration gradient
Vitamin D Receptor
13) Sulfroaphane and perhaps sulfurVitamin D Receptor
14) Butyrate especially gutVitamin D Receptor
15) BerberineVitamin D Receptor

Note: If you are not feeling enough benefit from Vitamin D, you might try increasing VDR activation. You might feel the benefit within days of adding one or more of the above

Far healthier and stronger at age 72 due to supplements Includes 6 supplements that help the VDR

Increased risk associated with a poor Vitamin D Receptor
   Note: Some diseases reduce VDR activation
those with a * are known to decrease activation

Health Problem
50Lyme Disease *
28Leprosy - another says 3X
15Chronic Heart Failure
15Temporary hair loss
14,7Childhood solid cancers
14Hand, Foot, and Mouth disease
12COVID Death
11Metabolic Syndrome
9.6Chronic Periodontitis
   and smoke
8Juvenile Rheumatoid Arthritis
7.6Crohn's disease
7.5Respiratory Tract Infections
5.8Low back pain in athletes
5 Respiratory Distress in preemies
5Ulcerative Colitis
5Coronary Artery Disease
5Asthma Child see also 1.3, 2.0 and 3.6
4.6Breast Cancer * 16.9 X another study
4.3Severe COVID in kids
4Polycystic ovary syndrome
3.6 Pneumonia - children
3.3 Pre-term birth
3.1 Colon Cancer survival
3 Multiple Sclerosis
3 Waist size
3 Ischemic Stroke
9X in women
3Gestational Diabetes
2.9Hand, Foot, Mouth Disease
2.8Osteoporosis & COPD
2.7Gastric Cancer
2.6Lupus in children
2.5 Lumbar Disc Degeneration
2.4Lung Cancer
2.2Juvenile idiopathic arthritis
2.1Adolescent idiopathic scoliosis in Asians
2Diabetic Retinopathy
2 Wheezing/Asthma see also 5X
2 Melanoma   Non-melanoma Skin Cancers
1.9Uterine Fibroids
1.9Early tooth decay
1.8Diabetic nephropathy
1.8Sleep Apnea
1.6Diabetes - Type I
1.6Prostate Cancer while black
1.5 Diabetes -Type II
1.4Graves Disease
1.4 Rheumatoid arthritis
1.3Childhood asthma see also 5X
1.3Psoriasis in Caucasians
?? Rickets - Vitamin D resistant

Breathing problems often associated with Poor Vitamin D Receptors

Publisher rents PDF for $9

Community-acquired pneumonia (CAP) is the leading cause of child deaths around the world. Recently, the vitamin D receptor (VDR) gene has emerged as a susceptibility gene for CAP.

To evaluate the association of the VDR gene Fok I polymorphism with susceptibility to CAP in Egyptian children.

This was a multicenter case-control study of 300 patients diagnosed with CAP, and 300 well-matched healthy control children. The VDR Fok I (rs2228570) polymorphism was genotyped by PCR-restriction fragment length polymorphism (RFLP), meanwhile serum 25-hydroxy vitamin D (25D) level was assessed using ELISA method.

The frequencies of the VDR FF genotype and F allele were more common in patients with CAP than in our control group (OR = 3.6; (95% CI: 1.9–6.7) for the FF genotype; P = 0.001) and (OR: 1.8; (95% CI: 1.4–2.3) for the F allele; P = 0.01). Patients carrying the VDR FF genotype had lower serum (25D) level (mean; 14.8 ± 3.6 ng/ml) than Ff genotype (20.6 ± 4.5 ng/ml) and the ff genotype (24.5 ± 3.7 ng/ml); P < 0.01.

The VDR gene Fok I (rs2228570) polymorphism confers susceptibility to CAP in Egyptian children.


1. Wardlaw, T., Salama, P., Johansson, E. W. & Mason, E. Pneumonia: the leading killer of children. Lancet 368, 1048–1050 (2006).

  • 2. Solé- Violán, J. et al. Genetic variability in the severity and outcome of community-acquired pneumonia. Respir. Med. 104, 440–447 (2010).
  • 3. Patwari, P. P. et al. Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr. Crit. Care. Med. 9, 553–559 (2008).
  • 4. Pike, J. W. & Meyer, M. B. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol. Metab. Clin. North. Am. 39, 255–269 (2010).
  • 5. Underwood, M. A. & Bevins, C. L. Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics 125, 1237–1247 (2010).
  • 6. Hossein-nezhad, A. & Holick, M. F. Vitamin D for health: a global perspective. Mayo Clin. Proc. 88, 720–755 (2013).
  • 7. Liu, P. T., Stenger, S., Tang, D. H. & Modlin, R. L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179, 2060–2063 (2007).
  • 8. Khoo, A. L. et al. Translating the role of vitamin D3 in infectious diseases. Crit. Rev. Microbiol. 38, 122–135 (2012).
  • 9. Muhe, L., Lulseged, S., Mason, K. E. & Simoes, E. A. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 349, 1801–1804 (1997).
  • 10. Banajeh, S. M. Nutritional rickets and vitamin D deficiency–association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr. Pulmonol. 44, 1207–1215 (2009).
  • 11. Manaseki-Holland, S. et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop. Med. Int. Health 15, 1148–1155 (2010).
  • 12. O Neill, V., Asani, F. F., Jeffery, T. J., Saccone, D. S. & Bornman, L. Vitamin D receptor gene expression and function in a South African population: ethnicity, vitamin D and FokI. PLoS ONE 8, e67663 (2013).
  • 13. Nejentsev, S. et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum. Mol. Genet. 13, 1633–1639 (2004).
  • 14. van Etten, E. et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 37, 395–405 (2007).
  • 15. Neuman, M. I., Monuteaux, M. C., Scully, K. J. & Bachur, R. G. Prediction of pneumonia in a pediatric emergency department. Pediatrics 128, 246–253 (2011).
  • 16. World Health Organization: Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. In WHO/V&B/01.35. Pneumonia Vaccine Trials Investigator’s Group. Geneva: World Health Organization; 2001:32.
  • 17. British Thoracic Society of Standards of Care Committee. BTS Guidelines for the management of community acquired pneumonia in childhood. Thorax 57, 1i–24i (2011).
  • 18. Goldstein, B., Giroir, B. & Randolph, A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care. Med. 6, 2–8 (2005).
  • 19. Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007).
  • 20. Mory, D. B. et al. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Hum. Immunol. 70, 447–451 (2009).
  • Show context for reference 20
  • Google Scholar
  • 21. Harris, M. et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 66(Suppl 2), ii1–ii23 (2011).
  • Show context for reference 21
  • Google Scholar
  • 22. Salimpour, R. Rickets in Tehran. Study of 200 cases. Arch. Dis. Child. 50, 63–66 (1975).
  • Show context for reference 22
  • Google Scholar
  • 23. Hughes, D. A. & Norton, R. Vitamin D and respiratory health. Clin. Exp. Immunol. 158, 20–25 (2009).
  • Show context for reference 23
  • Google Scholar
  • 24. Dürr, U. H., Sudheendra, U. S. & Ramamoorthy, A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758, 1408–1425 (2006).
  • Show context for reference 24
  • Google Scholar
  • 25. Raloff, J. The antibiotic vitamin: deficiency in vitamin D may predispose people to infection. Sci. News 170, 312–317 (2006).
  • Show context for reference 25
  • Google Scholar
  • 26. Edelson, J. D., Chan, S., Jassal, D., Post, M. & Tanswell, A. K. Vitamin D stimulates DNA synthesis in alveolar type-II cells. Biochim. Biophys. Acta 1221, 159–166 (1994).
  • Show context for reference 26
  • Google Scholar
  • 27. Gao, L., Tao, Y., Zhang, L. & Jin, Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberc. Lung. Dis. 14, 15–23 (2010).
  • Show context for reference 27
  • Google Scholar
  • 28. Han, W. G. et al. Association of vitamin D receptor polymorphism with susceptibility to symptomatic pertussis. PLoS ONE 11, e0149576 (2016).
  • Show context for reference 28
  • Google Scholar
  • 29. Kresfelder, T. L., Janssen, R., Bont, L., Pretorius, M. & Venter, M. Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J. Med. Virol. 83, 1834–1840 (2011).
  • Show context for reference 29
  • Google Scholar
  • 30. Li, W. et al. Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case–control study. Eur. J. Pediatr. 174, 621–629 (2015).
  • Show context for reference 30
  • Google Scholar
  • 31. Roth, D. E., Jones, A. D., Prosser, C., Robinson, J. L. & Vohra, S. Vitamin D receptor polymorphism and the risk of acute lower respiratory tract infection in early childhood. J. Infect. Dis. 197, 676–680 (2008).
  • Show context for reference 31
  • Google Scholar
  • 32. El Basha, N., Mohsen, M., Kamal, M. & Mehaney, D. Association of vitamin D deficiency with severe pneumonia in hospitalized children under 5 years. Comp. Clin. Pathol. 23, 1247–1252 (2014).
  • Show context for reference 32
  • Google Scholar
  • 33. Inamo, Y. et al. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr. Int. 53, 199–201 (2011).
  • Show context for reference 33
  • Google Scholar
  • 34. Monticielo, O. A. et al. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21, 43–52 (2012).
  • Show context for reference 34
  • Google Scholar
  • 35. Das, B., Patra, S., Behera, C. & Suar, M. Genotyping of vitamin D receptor gene polymorphisms using mismatched amplification mutation assay in neonatal sepsis patients of Odisha, eastern India. Infect. Genet. Evol. 45, 40–47 (2016).
  • Show context for reference 35
  • Google Scholar
  • 36. Møller, S., Laigaard, F., Olgaard, K. & Hemmingsen, C. Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis. Int. J. Med. Sci. 4, 190–195 (2007).
  • Show context for reference 36
  • Google Scholar
  • 37. Liu, P. T. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770–1773 (2006).
  • Show context for reference 37
  • Google Scholar
  • 38. Jeng, L. et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med. 7, 28 (2009).
  • Show context for reference 38
  • Google Scholar
  • 39. Lee, P., Nair, P., Eisman, J. A. & Center, J. R. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med. 35, 2028–2032 (2009).
  • 40. Aird, W. C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101, 3765–3777 (2003).
  • 41. Kamen, D. L. & Tangpricha, V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med. 88, 441–450 (2010).
  • 42. Yorita, K. L. et al. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii. Pediatr. Infect. Dis. J. 26, 1081–1088 (2007).

We thank the staff of Pediatric Pulmonology and Outpatient Clinics in Zagazig University, Ain-Shams and Cairo University hospitals for their collaboration in sampling as well as our patients who participated in the study.
Author contributions
H.A.Z. submitted the manuscript. M.A.A. designed the study. A.M.K. collected clinical data and coordinated the sample collection (Zagazig University). N.M.A. collected clinical data and coordinated the sample collection (Ain-Shams University). M.M.S. collected clinical data and coordinated the sample collection (Cairo University). M.S.H. and H.A.A.E. performed the statistical analysis. M.A.N. and A.A.S. helped to draft the manuscript. A.M.S., A.A.M., and M.E.H. wrote the manuscript. A.A.A., M.T.Z., and S.S.A.E. critically revised the final version. A.M.A., R.M.N., and G.M.A. performed laboratory analysis and genotyping. All authors read and approved all the manuscript.
Author information
Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Heba Abouzeid, Mohammed A. Abdou, Mohammed E. Hamed, Attia A. Soliman, Maha A. Noah, Atef M. Khalil, Mohamed S. Hegab, Alsayed Abdel-Aziz & Shaimaa S. A. Elashkar
Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
NourEldin M. Abdelaal
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
Amira A. A. Mosabah, Mervat T. Zakaria, Mohammed M. Soliman & Ashraf M. Sherif
Department of Clinical pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Rehab M. Nabil & Ghada M. Al-Akad
Department of Clinical pathology, Al Azhar Faculty of Medicine, Cairo, Egypt
Adel M. Abdou
Department of Internal Medicine, Faculty of Medicine, Menoufia University, Monufia, Egypt
Hany A. A. Elbasyouni
Competing interests
The authors declare no competing interests.
Corresponding author
Correspondence to Heba Abouzeid.

Created by admin. Last Modification: Thursday April 1, 2021 02:25:37 GMT-0000 by admin. (Version 7)